Form 8.5 (EPT/RI) - Tesco plc FORM 8.5 (EPT/RI)

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
70
Form 8.5 (EPT/RI) - Tesco plc

FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

1.         KEY INFORMATION

(a) Name of exempt principal trader:   Investec Bank plc  
(b) Name of offeror/offeree in relation to whose relevant securities this form relates:      Use a separate form for each offeror/offeree   Tesco plc
(c) Name of the party to the offer with which exempt principal trader is connected:     Investec are Broker to Booker Group plc  
(d) Date dealing undertaken:    20th February 2017  
(e) Has the EPT previously disclosed, or is it today disclosing, in respect of any other party to this offer? Yes

2.         DEALINGS BY THE EXEMPT PRINCIPAL TRADER

(a)        Purchases and sales

Class of relevant security Purchases/ sales   Total number of securities Highest price per unit paid/received (pence)   Lowest price per unit paid/received (pence)
  Ordinary Voting Shares     Purchases   59,125   193.35   194.1
  Ordinary Voting Shares     Sales   59,125   196.25   194

(b)        Derivatives transactions (other than options)

Class of relevant security Product description e.g. CFD Nature of dealing e.g. opening/closing a long/short position, increasing/reducing a long/short position Number of reference securities Price per unit
           

(c)        Options transactions in respect of existing securities

(i)         Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type e.g. American, European etc. Expiry date Option money paid/ received per unit
               

(ii)        Exercising

Class of relevant security Product description e.g. call option Number of securities Exercise price per unit
         

(d)        Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing e.g. subscription, conversion Details Price per unit (if applicable)
         

The currency of all prices and other monetary amounts should be stated.

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

3.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer: If there are no such agreements, arrangements or understandings, state "none"
  None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to: (i)  the voting rights of any relevant securities under any option; or (ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced: If there are no such agreements, arrangements or understandings, state "none"
  None
  Date of disclosure: 21st February 2017
  Contact name:   Jacqueline Lovis
  Telephone number:   020 7597 4815
Scroll down for more posts ▼

Top 10 Most Recent News Articles

PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 9

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 5

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 5

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
D-Wave Faces Legal Questions After CFO Exit and Losses

Updated Category News Views 2

Trouble Brews at D-Wave Quantum Smack in the middle of market chaos, D-Wave Quantum Inc. (NASDAQ: QBTS) seems to have hit a rather gnarly pothole. With disappointing revenue figures for Q2 of 2026—coming in at a measly $3.08 million, far below the expected range of $4.03 million to $4.08 million—investors have more than enough reasons to be irked. When the numbers...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 4

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 2

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 10

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 9

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading

Top 5 Most Recently Viewed Articles

AP Memory Taps Qualcomm Vet Jian Zhang for Growth

Updated Category News Views 9

AP Memory's Strategic Move with Jian Zhang In the ceaseless chess game that is the semiconductor industry, AP Memory's latest play is nothing short of intriguing. They've snagged Jian Zhang to bolster their ranks, which looks like a smart bet for anyone keeping an eye on memory solutions. A seasoned pro in the semiconductor trenches, Jian isn't just bringing a resume;...

Continue Reading
ACADIA Pharmaceuticals: Key Insights Ahead of Earnings Call

Updated Category News Views 145

ACADIA Pharmaceuticals Set for Earnings Report ACADIA Pharmaceuticals (NASDAQ: ACAD) is preparing to announce its latest quarterly earnings report this week. The anticipation surrounding this report is palpable, as investors are eager for insights regarding the company's potential performance and stock trajectory in the upcoming period. Expected Earnings and Market...

Continue Reading
João Carlos Martins' Farewell Concert at Carnegie Hall

Updated Category News Views 202

João Carlos Martins' Unforgettable Farewell at Carnegie Hall World-renowned pianist and conductor João Carlos Martins takes the spotlight once again, leading NOVUS in a captivating concert that pays tribute to the influential works of renowned composers. The evening focuses on the legacy of J.S. Bach and his significant impact on leading Brazilian composer Heitor...

Continue Reading
Understanding the Securities Class Action Investigation for FLY

Updated Category News Views 218

Insights into Firefly Aerospace’s Class Action Investigation Recent developments concerning Firefly Aerospace Inc. (NASDAQ: FLY) have drawn the attention of both shareholders and legal experts. The investigation led by renowned investor rights legal team, Rosen Law Firm, highlights potential securities claims related to the company’s disclosures. Such scrutiny is...

Continue Reading
Silicon Motion Unveils New $50 Million Share Buyback Initiative

Updated Category News Views 242

Overview of the Share Repurchase Program TAIPEI, Taiwan and MILPITAS, Calif. — Silicon Motion Technology Corporation (NASDAQ: SIMO) has exciting news regarding its financial strategies. The company recently announced that its Board of Directors has initiated a share repurchase program, enabling it to buy back up to $50 million of its American Depositary Shares (ADSs)...

Continue Reading